Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

eHealth in Treatment of Gestational Diabetes (eMOMGDM)

NCT: NCT04714762 · ACTIVE_NOT_RECRUITING

NCT IDNCT04714762
StatusACTIVE_NOT_RECRUITING
Start Date2021-03-10
Completion2027-12-31
SponsorHelsinki University Central Hospital (OTHER)
First posted
Last updated

Brief Summary

The overall aim of the eMOM GDM-project is to develop and evaluate a novel system to clinical decision making and patient behavior change in treatment of GDM, combining diet, physical activity, sleep, heart rate (e.g. stress), and glucose monitoring within a single system (the eMOM GDM application), and linking the developed application tool for the normal health care system in a new way. In this second phase of the project, the effect of eMOM GDM application on maternal and neonatal outcomes will be evaluated in a randomized controlled study design. The follow-up study continues until 3 months postpartum.

Frequently Asked Questions

What is eHealth in Treatment of Gestational Diabetes (eMOMGDM)?

eHealth in Treatment of Gestational Diabetes (eMOMGDM) is a clinical trial registered under NCT04714762. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04714762?

The current status of NCT04714762 (eHealth in Treatment of Gestational Diabetes (eMOMGDM)) is: ACTIVE_NOT_RECRUITING.

When did eHealth in Treatment of Gestational Diabetes (eMOMGDM) start?

eHealth in Treatment of Gestational Diabetes (eMOMGDM) started on 2021-03-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑